200 Henry Clay Ave, New Orleans, LA, 70118 · (504) 899-9511
Beds
204
FY 2025
Star rating
Not rated
Overall rating
Net patient revenue
$687.3M
FY 2025
Net income
$270.6M
Patient care margin 13.0%
Discharges
5,233
Occupancy 61.0%
Clinicians
57
Medicare clinicians who work here
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $687.3M | $597.8M | 13.0% | $270.6M | 5,233 | - | 0.5% | 71.0% |
Medicare clinicians who list this hospital, by specialty
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5153 Level 3 Airway Endoscopy | - | - | - | $1,264.08 |
| APC 5373 Level 3 Urology and Related Services | - | - | - | $1,516.28 |
| APC 5374 Level 4 Urology and Related Services |
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
| 2024 | $641.2M | $543.2M | 15.3% | $205.8M | 5,579 | - | 0.5% | 68.3% |
| 2023 | $634.5M | $521.3M | 17.8% | $267.6M | 5,579 | - | 0.6% | 71.0% |
| 2022 | $523.4M | $488.4M | 6.7% | -$153.2M | 5,927 | - | 0.8% | 73.4% |
| 2021 | $398.5M | $424.7M | -6.6% | $110.6M | 5,300 | - | 1.3% | 75.2% |
| 2020 | $358.7M | $372.6M | -3.9% | $169.8M | 4,738 | - | 1.4% | 74.5% |
| - |
| - |
| - |
| $2,629.24 |
| APC 8011 Comprehensive Observation Services | - | - | - | $2,090.36 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 25 | $64K |
| Janssen Research & Development, LLC JNJ | 9 | $39K |
| Eli Lilly and Company LLY | 4 | $26K |
| Syndax Pharmaceuticals, Inc. SNDX | 2 | $11K |
| National Marrow Donor Program | 5 | $4,985 |
| Pfizer Inc. PFE | 2 | $4,600 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $275 |
| Chiesi USA, Inc. | 1 | $255 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $25 |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Childrens Hospital is a nonprofit children's hospital in New Orleans, LA with 204 beds, part of LCMC Health System.
Childrens Hospital in New Orleans, LA has 204 beds (fiscal year 2025 cost report); 227 beds are certified for Medicare. It discharged 5,233 inpatients that year, with 61.0% of its beds in use on average.
In fiscal year 2025 (ending 2025-12-31), Childrens Hospital reported net patient revenue of $687.3M and operating expenses of $597.8M, a margin on patient care of 13.0%. After other income and expenses its net income was $270.6M (31.2% of revenue), so it made a profit that year.
Childrens Hospital is part of LCMC Health System, a health system with 7 hospitals based in New Orleans, LA. It is a nonprofit hospital.
Childrens Hospital has no overall star rating, usually because it reports too few quality measures (for example small, specialty or federal hospitals).
Yes, Childrens Hospital provides emergency services.
57 Medicare clinicians list Childrens Hospital as a hospital they work at, most often in Pediatric Medicine, Diagnostic Radiology, General Surgery.
In 2025, companies reported $151K in payments to Childrens Hospital as a teaching hospital ($4,010 general and $147K for research) from 9 companies.